M&A in Pharmaceuticals and Medical Devices: How to Stop Value Leakage

M&A in Pharmaceuticals and Medical Devices: How to Stop Value Leakage

Most pharmaceutical executives would argue that M&A is critical to drive shareholder value. Transactions can help realize new discovery capabilities, procure new compounds to strengthen stagnant drug development pipelines, or save money, all of which can create a competitive advantage in the market.  The numbers speak for themselves. In 2015, healthcare M&A increased 66%, reaching a...

Read More
Phone: 312-602-4000
Email: marketing@westmonroepartners.com
222 W. Adams
Chicago, IL 60606
Show Buttons
Share On Facebook
Share On Twitter
Share on LinkedIn
Hide Buttons